معرفی
Paul Fraser Kantor is a Clinical Professor of Pediatrics and Division Chief of Cardiology at the Keck School of Medicine of USC. He serves as Co-Executive Director of the Heart Institute at Children's Hospital Los Angeles (CHLA), leading clinical and research initiatives in pediatric cardiovascular medicine. His work focuses on advancing care for children with heart failure, cardiomyopathies, and genetic cardiovascular disorders.
Dr. Kantor's research emphasizes translational studies in pediatric heart failure, including clinical trials like the PANORAMA-HF study evaluating sacubitril/valsartan efficacy, and genetic investigations into cardiomyopathy etiologies. He has pioneered biomarker analysis (e.g., NT-proBNP, BNP) for prognostication and management optimization. His work also explores imaging techniques like cardiac MRI T1 mapping to assess myocardial fibrosis.
Publications highlight his contributions to understanding hypertrophic cardiomyopathy's genetic underpinnings, sudden cardiac death risk stratification, and outcomes in dilated cardiomyopathy. He has authored over 150 peer-reviewed articles, focusing on pediatric-specific cardiac pathophysiology.
His clinical leadership includes directing multidisciplinary teams at CHLA's Heart Institute, managing complex cases such as congenital heart disease, heart transplantation, and mechanical circulatory support.